The study developed a prognostic nomogram for gastric cancer patients post-neoadjuvant chemotherapy and radical surgery, revealing promising results. The median progression-free survival was 43.8 months, and overall survival reached 61.2 months. The nomogram demonstrated excellent discrimination with a c-index of 0.689 and area under the curve (AUC) values of 0.778, 0.746, and 0.725 for 3-, […]
Category: Upper Gastrointestinal Tract
Early detection of infectious complications post-gastric cancer surgery
Elevated interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels in serum and drainage fluid indicate infectious complications following minimally invasive gastric cancer surgery. Among 205 patients, pod 1 serum IL-6 levels above 47 pg/ml exhibited 74.1% sensitivity, while drainage fluid IL-6 levels over 14,750 pg/ml demonstrated 100% sensitivity for intra-abdominal abscess detection. These findings suggest […]
Causal relationships exist between biliary disorders and GERD.
Significant causal effects of genetically predicted cholelithiasis, cholecystitis, and cholecystectomy on gastroesophageal reflux disease (GERD) were identified, with odds ratios of 1.04, 1.06, and 2.56, respectively. Additionally, the study confirmed a bidirectional relationship, where GERD also influences the likelihood of developing cholelithiasis and cholecystitis. Mediation analyses showed that both biliary disorders and GERD partially mediate […]
Neoadjuvant chemotherapy significantly improves survival in gastric cancer.
Findings indicate that neoadjuvant chemotherapy (ctx) for resectable gastric cancer results in significantly longer overall survival (OS) compared to neoadjuvant chemoradiation (crtx). Analysis of 14,266 patients revealed a 20%-30% improvement in 5-year OS for the ctx group, despite a higher prevalence of complete pathological response in the crtx cohort. The study posits that current AJCC […]
Core indicators established for oesophagogastric cancer management
A consensus reached by experts identified key quality performance indicators for management of oesophagogastric cancer, enhancing patient care and outcomes. The two-round modified Delphi process resulted in a standardized list which includes specialized multi-disciplinary discussions, pertinent imaging and staging procedures, as well as specific surgical benchmarks. Notably, indicators unique to gastric and oesophageal cancers were […]
Nomograms effectively predict treatment outcomes in esophageal cancer patients.
In a study of 188 patients undergoing neoadjuvant therapy for locally advanced esophageal cancer, researchers developed predictive nomograms showing strong performance for estimating tumor regression grade (TRG) and ypTNM stage. Notably, 129 patients reached TRG grades 0-1, while 118 achieved ypTNM stage I. Five independent TRG predictors included pulmonary function tests and combination immunotherapy. The […]
Total neoadjuvant therapy shows promising survival in gastric cancer.
A study involving 203 gastric cancer patients revealed that total neoadjuvant therapy (TNT) resulted in a 5-year overall survival (OS) rate of 65.2% and a disease-specific survival (DSS) rate of 70.8%. Notably, patients achieving pathologic complete response (PCR) had significantly better outcomes, with 5-year OS at 89.1% and DSS at 96.9%. High rates of treatment […]
CHAMPS Score Outperforms Existing Tools in Predicting Mortality
The CHAMPS score proved highly effective in predicting mortality in patients with non-variceal upper gastrointestinal bleeding, showing an area under the receiver operating characteristic curve (AUROC) of 0.89. It significantly outperformed the Glasgow-Blatchford score (0.72) and AIM65 score (0.71). In low-risk categories, mortality and rebleeding rates were zero; however, 58.8% of patients in the low-risk […]
Prognostic models enhance survival predictions for gastric carcinoma
Development and validation of prognostic models for gastric carcinoma were achieved using data from 1,650 patients post-gastrectomy. The nomogram for node-negative lymphatic metastasis (c-index 0.719) and node-positive metastasis (c-index 0.674) outperformed the AJCC 8th edition TNM staging. Key variables included age, tumor stage, and maximum diameter for node-negative cases, while additional factors like neural invasion […]
Higher frailty predicts serious complications in gastric cancer surgery
Increased frailty, as measured by the modified 5-item frailty index (mFI-5), significantly predicts adverse postoperative outcomes for gastric cancer patients undergoing gastrectomy. Among 7,438 patients, those with an mFI-5 score of 2 or higher faced a 1.43 times greater risk of overall complications and a 2.91 times increased risk of myocardial infarction. This correlation underscores […]